Eileen Wong, MD
Sleep Medicine · Streetsboro, OHNPI 1275841066
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. ZOLL Respicardia, Inc. accounts for 62.1% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $3,387 and has fallen 78.6% since, to $726 in 2025.
Across 45 payments — averaging $98.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Respicardia, Inc.$3K
- Jazz Pharmaceuticals Inc.$660
- Avadel CNS Pharmaceuticals, LLC$216
- Inspire Medical Systems, Inc.$213
- Harmony Biosciences LLC$156
- Fisher & Paykel Healthcare Inc$77
- plus $356 from 10 others
What the payments were for
- Consulting fees$3007%
- Travel & lodging$1,80641%
- Food & beverage$1,98945%
- Education$3368%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Respicardia, Inc. | 6 | $2,753 |
| Jazz Pharmaceuticals Inc. | 6 | $660 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $216 |
| Inspire Medical Systems, Inc. | 3 | $213 |
| Harmony Biosciences LLC | 4 | $156 |
| Fisher & Paykel Healthcare Inc | 3 | $77 |
| Axsome Therapeutics, Inc. | 4 | $73 |
| Philips North America LLC | 3 | $60 |
| Resmed Corp | 2 | $43 |
| Actelion Pharmaceuticals US, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $35 |
| Merck | 1 | $29 |
| 3b Medical, Inc. | 2 | $25 |
| Baxter Healthcare | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- remede System$2,644
- XYWAV$299
- Inspire$171
- XYREM$150
- LUMRYZ$150
How this compares
$4,431 in reported general payments places this provider in the 75th percentile of 94 sleep medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HetliozTasimelteon | 13 | $311,064 |
| NeuproRotigotine | 17 | $13,154 |
| Azelastine Hcl | 13 | $867 |
| Fluticasone Propionate | 60 | $656 |
| Ropinirole Hcl | 29 | $368 |
| Gabapentin | 18 | $42 |
| Alprazolam | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Streetsboro
- Asim RoyDublin$666K
- Shahrokh JavaheriCincinnati$404K
- Louis TartagliaMaumee$314K
- John AndrefskyParma$147K
- Anthony SuchoskiCincinnati$89K
- Nancy Foldvary-SchaeferCleveland$75K
- Shayla PullenCincinnati$71K
- Gautam SamadderColumbus$53K
- Kevin CarterBeavercreek$49K
- Brian ChenCleveland$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.